Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Vaccination in At-Risk Youth
NCT00107042Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Feb 2004
- Primary completion
- Jul 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of Recombivax HB, hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by University of North Carolina at Chapel Hill. Started Feb 2004; status: completed.
02
Drugs
Recombivax HBhepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00107042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107042.